Modified natural cycle for in vitro fertilization and embryo transfer in normal ovarian responders

Journal of International Medical Research

Volumn 38, Issue 6, 2010, Pages 2070-2076

  Lou, H Y ^a   Huang, X Y ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gonadotrophins; In vitro fertilization; Infertility; Natural cycle; Ovarian stimulation; Pregnancy rate

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; EVENING DOSAGE; FEASIBILITY STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; MENSTRUAL CYCLE; MODIFIED NATURAL CYCLE; MORNING DOSAGE; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL;

EID: 78650844598     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800622     Document Type: Article

References (25)

1. Steptoe PG, Edwards RG: Birth after the reimplantation of a human embryo. Lancet 1978; ii: 366.
2. Claman P, Domingo M, Garner P, et al: Natural cycle in vitro fertilization-embryo transfer at the University of Ottawa: an inefficient therapy for tubal infertility. Fertil Steril 1993; 60: 298-302.
3. Sills ES, Levy DP, Moomjy M, et al: A prospective, randomized comparison of ovulation induction using highly purified follicle stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Hum Reprod 1999; 14: 2230-2235.
4. Balasch J, Fábregues F, Creus M, et al: Pure and highly purified follicle stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Hum Reprod 1996; 14: 2400-2404.
5. Fried G, Harlin J, Csemiczky G, et al: Controlled ovarian stimulation using highly purified FSH results in a lower serum oestradiol profile in the follicular phase as compared with HMG. Hum Reprod 1996; 11: 474-477.
6. Elchalal U, Schenker JG: The pathophysiology of ovarian hyperstimulation syndrome - view and ideas. Hum Reprod 1997; 12: 1129-1137.
7. Elster N: Less is more: the risk of multiple births. The Institute for Science, Law, and Technology Working Group on Reproductive Technology. Fertil Steril 2000; 74: 617-623.
8. Bergh T, Ericson A, Hillenjsö T, et al: Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet 1999; 354: 1579-1585.
9. Duckitt K, Templeton AA: Cancer in women with fertility. Curr Opin Obstet Gynecol 1998; 10: 199-203.
10. Huang XY, Wang HW, Zhao XF, et al: Gestational trophoblastic disease following in-vitro fertilization. Arch Gynecol Obstet 2007; 275: 291-293.
11. Nargund G, Frydman R: Towards a more physiological approach to IVF. Reprod Biomed Online 2007; 14: 550-552.
12. Bauman R, Mihaljević D, Kupesić S, et al: In vitro fertilization in spontaneous cycles - our experience. Eur J Obstet Gynecol Reprod Biol 2002; 102: 184-187.
13. Feldman B, Seidman DS, Levron J, et al: In vitro fertilization following natural cycles in poor responders. Gynecol Endocrinol 2001; 15: 328-334.
14. Lukassen HG, Kremer JA, Lindeman EJ, et al: A pilot study of the efficacy of intracytoplasmic sperm injection in a natural cycle. Fertil Steril 2003; 79: 231-232.
15. Ubaldi F, Rienzi L, Baroni E, et al: Hopes and facts about mild ovarian stimulation. Reprod Biomed Online 2007; 14: 675-681.
16. Nygren KG: Single embryo transfer: the role of natural cycle/minimal stimulation IVF in the future. Reprod Biomed Online 2007; 14: 626-627.
17. Lim JH, Yang SH, Chian RC: New alternative to infertility treatment for women without ovarian stimulation. Reprod Biomed Online 2007; 14: 547-549.
18. Janssens RMJ, Lambalk CB, Vermeiden JPW, et al: In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic. Hum Reprod 2000; 15: 314-318.
19. Ubaldi F, Rienzi L, Ferrero S, et al: Natural in vitro fertilization cycles. Ann NY Acad Sci 2004; 1034: 245-251.
20. Pelinck MJ, Vogel NE, Hoek A, et al: Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetroelix and concomitant substitution with recombinant FSH: a pilot study. Hum Reprod 2005; 20: 642-648.
21. Morgia F, Sbracia M, Schimberni M, et al: A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril 2004; 81: 1542-1547.
22. Veeck LL: Fertilization and early embryonic development. Curr Opin Obstet Gynecol 1992; 4: 702-711.
23. Ben-Chetrit A, Gotlieb L, Wong PY, et al: Ovarian response to recombinant human follicle- stimulating hormone in luteinizing hormone- depleted women: examination of the two cell, two gonadotropin theory. Fertil Steril 1996; 10: 1719-1724.
24. Pelinck MJ, Hoek A, Simons AH, et al: Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update 2002; 8: 129-139.
25. Oberye JJ, Mannaerts BM, Huisman JA, et al: Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers. Fertil Steril 1999; 72: 1006-1012.